View Author
scopus: 14631434700

Wolterbeek, R.

(Ron Wolterbeek)


group patient study laser surgery voice brca 1/2 offspring offspring radiotherapy treatment effect laser surgery group statin radiotherapy group 1/2 laser surgery disease hd offspring parent atorvastatin cholesterol level difference carcinoma activity voice quality glottic control rosuvastatin brca 1/2 cancer erasmus mc plasma lipoprotein metabolism karalis quality result lipoprotein childhood lipid metabolism analysis table person protein signi ficantly score value baseline transfer statin doses therapy number apolipoprotein reduction erasmu huntington abuse experience downloaded testing dysfunction period profile hdl-c lesion population enzyme event center modification participant cholesterol transport netherland statin therapy research treatment regimens pltp activity midcord apoai particle




3 Most Recent Publications

Adverse childhood experiences of persons at risk for Huntington's disease or BRCA1/2 hereditary breast/ovarian cancer (Article)
Meer, L.B. van der Duijn, E.B. van Wolterbeek, R. Tibben, A.
2012-01-01
Effect of increasing doses of Rosuvastatin and Atorvastatin on apolipoproteins, enzymes and lipid transfer proteins involved in lipoprotein metabolism and inflammatory parameters (Article)
Karalis, I.K. Bergheanu, S.C. Wolterbeek, R. Dallinga-Thie, G.M. Hattori, H. Tol, A. van Liem, A.H. Jukema, J.W.
2010-10-01
Voice outcome in Tla midcord glottic carcinoma (Article)
Sjögren, E.V. Rossum, M.A.J. van Langeveld, T.P.M. Voerman, M.S. Kamp, V.A.H. van de Friebel, M.O.W. Wolterbeek, R. Jong, R.J.B. de
2008-09-01